Welcome to the inaugural issue of CHPR—our fourth CME newsletter. Unlike our other newsletters, which are focused on outpatient practice, the focus of CHPR is on hospital psychiatry, including inpatient units, emergency rooms, and consult liaison work.

We’re pleased to introduce Victoria Hendrick, MD, as CHPR’s editor-in-chief. Dr. Hendrick is a clinical professor at the David Geffen School of Medicine at UCLA and the director of inpatient psychiatry at Olive View UCLA Medical Center, where she carries a caseload of patients and teaches and supervises medical students and psychiatry residents.

Topics: Depression | Esketamine | Fast-acting | Free Articles | Intra-nasal | Ketamine | Management | Psychopharmacology | Suicidality

Imagine a drug that resolves depression within hours in people at imminent risk of suicide. Esketamine may be such a drug — but is it a miracle cure? Here we look at the data and discuss the pros and cons of this new treatment.

Topics: Free Articles | Serotonin

Dr. Laura Tormoehlen discusses the management of neuroleptic malignant syndrome and serotonin syndrome and summarizes how to distinguish between these acute conditions.

Topics: Borderline Personality Disorder | Deliberate foreign body ingestion | DFBI | Free Articles | Gastroenterology | Malingering | Management | Obsessive compulsive disorder/OCD | Personality Disorders | Pica | Psychosis | Self-injury | Swallowing

Why would anyone deliberately swallow a nondigestible object? What items require emergent removal, vs simple monitoring? And how can you help patients who repeatedly swallow foreign bodies?

Topics: Adjunct treatment | Antidepressant | Antipsychotic | Benzodiazepine | CATIE | Combination treatment | Free Articles | Mood stabilizer | Outcomes | Psychopharmacology | Schizoaffective disorder | Schizophrenia | Substance Use Disorder

Dr. T. Scott Stroup, Professor of Psychiatry at Columbia University, reveals surprising findings from his research on the use of adjunctive medications for schizophrenia.

Topics: Antipsychotics | Free Articles | Research Update

How high should we go when dosing antipsychotics in schizophrenia? A recent meta-analysis of 68 studies examined dose-response relationships in randomized controlled trials of antipsychotic medications for schizophrenia and schizoaffective disorder.

Topics: CME Post-Test

The post-test for this issue is available for one year after the publication date to subscribers. By successfully completing the test you will be awarded a certificate for 2 CME credits.